The prevalence of irregular antibodies in pregnancy; a prospective investigation in the 's-Hertogenbosch area;Het voorkomen van irregulaire antistoffen in de zwangerschap; een prospectief onderzoek in de regio 's-Hertogenbosch

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 50, 1999, Pages 2523-2527

  De Vrijer, B ^a   Harthoorn Lasthuizen, E J ^a   Oosterbaan, H P ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; ALLOANTIBODY; BLOOD GROUP ANTIGEN;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; FIRST TRIMESTER PREGNANCY; HUMAN; NETHERLANDS; NEWBORN HEMOLYTIC DISEASE; SCREENING TEST; ADULT; BLOOD; BLOOD GROUP INCOMPATIBILITY; FEMALE; HEALTH SURVEY; IMMUNOLOGY; INCIDENCE; MASS SCREENING; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; PROSPECTIVE STUDY; STATISTICS; SURVIVAL RATE;

ADULT; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; ISOANTIBODIES; MASS SCREENING; NETHERLANDS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREVALENCE; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0033547519     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mollison PL. Blood transfusion in clinical medicine. 7th ed. Oxford: Blackwell Scientific: 1993. p. 344-67.
2. Dijk BA van. Irregulair bloedgroepantagonisme: een geregeld probleem [proefschrift]. Leiden: Rijksuniversiteit: 1991.
3. Dijk BA van, Overbeeke MAM, Bennehroek Gravenhorst J. Irregulaire erytrocytenantistoffen tijdens de zwangerschap. Ned Tijdschr Geneeskd 1985;129:1361-4.
4. Bowell PJ, Allen DL, Entwistle CC. Blood group antibody screening lests during pregnancy. Br J Obstet Gynaecol 1986;93:1038-43.
5. Mickley H. Haemolytic disease of the newborn due to antibodies other than rhesus anti-D [letter]. Br Med J (Clin Res Ed) 1981; 283:1605-6.
6. Solola A, Sibai B, Mason JM. Irregular antibodies: an assessment of routine prenatal screening. Obstet Gynecol 1983;61:25-30.
7. Wilken H. Aktuelle Probleme der Blutgruppenunvertraglichkeit in der Schwangerschaft. Zentralbl Gynakol 1988:110:1-11.
8. IGZ Bulletin Bloedonderzoek in de zwangerschap. Rijswijk/Amstelveen: Ziekenfondsraad: juni 1998.
9. Lapierre Y, Rigal D, Adam J, Josef D, Meyer F, Greher S, et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990;30:109-13.
10. Walker RH, editor. Technical manual. 11th ed. Bethesda: American Association of Blood Banks; 1993. p. 661-4.
11. Hardy J, Napier JAF. Red cell antibodies detected in antenatal tests on rhesus positive women in South and Mid Wales, 1948-1978. Br J Obstet Gynaecol 1981;88:91-100.
12. Luban NLC. Hemolytic disease of the newborn: progenitor cells and late effects. N Engl J Med 1998;338:830-1.
13. Hoffmann JJML, Hutter AP, Loomans AAH, Tielens AGWM. Neonataal bloedgroepantagonisme door anti-M-antistoffen. Ned Tijdschr Geneeskd 1991;135:805-7.
14. Overbeeke MAM. Dudok dc Wit C. Preventie van de immunisatie tegen erytrocytenantigenen c, E en K veroorzaakt door bloedtransfusie. Ned Tijdschr Geneeskd 1994;138:1116-8.
15. Castel A, Dijk BA van, Boom FMLG van den, Brand A, Engelfriet CP, Overbeeke MAM, et al. Preventie van immunisatie door c, E en K: achtergronden en gefaseerde implementatie. Nederlands TiJdschrift voor Klinische Chemie 1996;21:3-7.
16. Leggat HM, Gibson JM, Barron SL, Reid MM. Anti-Kell in pregnancy. Br J Obstet Gynaecol 1991;98:162-5.
17. Mayne KM, Bowell PJ, Pratt GA. The significance of anti-Kell sensitization in pregnancy. Clin Lab Haematol 1990;12:379-85.
18. Astrup J, Kornstad L. Presence of anti-c in the serum of 42 women giving birth to c positive babies: serological and clinical findings. Acta Obstet Gynecol Scand 1977;56:185-8.
19. Tannirandorn Y, Rodeck CH. New approaches in the treatment of haemolytic disease of the fetus. Baillieres Clin Haematol 1990;3: 289-320.